| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.95▲ | 4.95▲ | 4.96▲ | 5.06▼ | 5.87▼ |
| MA10 | 4.91▲ | 4.96▲ | 5.07▼ | 5.10▼ | 5.97▼ |
| MA20 | 4.93▲ | 5.09▼ | 5.15▼ | 5.88▼ | 5.96▼ |
| MA50 | 5.01▼ | 5.09▼ | 4.90▲ | 6.13▼ | 5.54▼ |
| MA100 | 5.14▼ | 4.90▲ | 5.56▼ | 5.99▼ | 7.19▼ |
| MA200 | 5.05▼ | 5.62▼ | 6.28▼ | 5.84▼ | 10.07▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.013▲ | -0.020▼ | -0.039▼ | -0.090▼ | -0.104▼ |
| RSI | 55.692▲ | 45.568▼ | 46.786▼ | 43.769▼ | 44.679▼ |
| STOCH | 68.654 | 24.979 | 10.237▼ | 27.165 | 29.905 |
| WILL %R | 0.000▲ | -65.556 | -73.504 | -82.215▼ | -89.537▼ |
| CCI | 146.472▲ | -38.859 | -75.142 | -42.409 | -117.488▼ |
|
Wednesday, July 09, 2025 12:59 PM
On Wednesday, Unicycive Therapeutics (NASDAQ:UNCY) maintained its Buy rating and $4.50 price target from investment firm H.C ...
|
|
Tuesday, July 08, 2025 08:03 AM
Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients ...
|
|
Tuesday, July 08, 2025 05:43 AM
LOS ALTOS, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/07/25 | 5.19 | 5.26 | 4.83 | 5.01 | 807,248 |
| 10/07/25 | 5.55 | 5.55 | 5.12 | 5.25 | 907,415 |
| 09/07/25 | 5.00 | 5.42 | 4.90 | 5.38 | 919,034 |
| 08/07/25 | 4.70 | 5.0796 | 4.62 | 4.97 | 627,873 |
| 07/07/25 | 4.55 | 4.81 | 4.34 | 4.69 | 596,855 |
| 03/07/25 | 4.64 | 4.6502 | 4.31 | 4.60 | 810,242 |
| 02/07/25 | 4.93 | 4.985 | 4.51 | 4.64 | 920,755 |
| 01/07/25 | 5.00 | 5.04 | 4.805 | 4.90 | 1,392,556 |
| 30/06/25 | 5.45 | 5.6999 | 4.755 | 4.77 | 4,706,462 |
| 27/06/25 | 5.89 | 7.15 | 5.61 | 6.80 | 1,798,900 |
|
|
||||
|
|
||||
|
|